Literature DB >> 25952288

Mapping brain volumetric abnormalities in never-treated pathological gamblers.

Daniel Fuentes1, Patricia Rzezak2, Fabricio R Pereira2, Leandro F Malloy-Diniz3, Luciana C Santos2, Fábio L S Duran2, Maria A Barreiros4, Cláudio C Castro5, Geraldo F Busatto6, Hermano Tavares7, Clarice Gorenstein8.   

Abstract

Several magnetic resonance imaging (MRI) studies to date have investigated brain abnormalities in association with the diagnosis of pathological gambling (PG), but very few of these have specifically searched for brain volume differences between PG patients and healthy volunteers (HV). To investigate brain volume differences between PG patients and HV, 30 male never-treated PG patients (DSM-IV-TR criteria) and 30 closely matched HV without history of psychiatric disorders in the past 2 years underwent structural magnetic resonance imaging with a 1.5-T instrument. Using Freesurfer software, we performed an exploratory whole-brain voxelwise volume comparison between the PG group and the HV group, with false-discovery rate correction for multiple comparisons (p < 0.05). Using a more flexible statistical threshold (p < 0.01, uncorrected for multiple comparisons), we also measured absolute and regional volumes of several brain structures separately. The voxelwise analysis showed no clusters of significant regional differences between the PG and HV groups. The additional analyses of absolute and regional brain volumes showed increased absolute global gray matter volumes in PG patients relative to the HV group, as well as relatively decreased volumes specifically in the left putamen, right thalamus and right hippocampus (corrected for total gray matter). Our findings indicate that structural brain abnormalities may contribute to the functional changes associated with the symptoms of PG, and they highlight the relevance of the brain reward system to the pathophysiology of this disorder.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Addiction; Hippocampus; Impulse control disorder; Magnetic resonance imaging; Putamen; Thalamus

Mesh:

Year:  2015        PMID: 25952288     DOI: 10.1016/j.pscychresns.2015.04.001

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  6 in total

1.  Gray-matter relationships to diagnostic and transdiagnostic features of drug and behavioral addictions.

Authors:  Sarah W Yip; Patrick D Worhunsky; Jiansong Xu; Kristen P Morie; R Todd Constable; Robert T Malison; Kathleen M Carroll; Marc N Potenza
Journal:  Addict Biol       Date:  2017-02-01       Impact factor: 4.280

2.  Abnormalities of striatal morphology in gambling disorder and at-risk gambling.

Authors:  Jon E Grant; Masanori Isobe; Samuel R Chamberlain
Journal:  CNS Spectr       Date:  2019-12       Impact factor: 3.790

Review 3.  Neuroimaging of reward mechanisms in Gambling disorder: an integrative review.

Authors:  Luke Clark; Isabelle Boileau; Martin Zack
Journal:  Mol Psychiatry       Date:  2018-09-13       Impact factor: 15.992

Review 4.  A biopsychological review of gambling disorder.

Authors:  Gabriel C Quintero
Journal:  Neuropsychiatr Dis Treat       Date:  2016-12-23       Impact factor: 2.570

5.  Altered orbitofrontal sulcogyral patterns in gambling disorder: a multicenter study.

Authors:  Yansong Li; Zixiang Wang; Isabelle Boileau; Jean-Claude Dreher; Sofie Gelskov; Alexander Genauck; Juho Joutsa; Valtteri Kaasinen; José C Perales; Nina Romanczuk-Seiferth; Cristian M Ruiz de Lara; Hartwig R Siebner; Ruth J van Holst; Tim van Timmeren; Guillaume Sescousse
Journal:  Transl Psychiatry       Date:  2019-08-05       Impact factor: 6.222

6.  Deficient Decision Making in Pathological Gamblers Correlates With Gray Matter Volume in Medial Orbitofrontal Cortex.

Authors:  Daniel Freinhofer; Philipp Schwartenbeck; Natasha Thon; Tina Eigenberger; Wolfgang Aichhorn; Melanie Lenger; Friedrich M Wurst; Martin Kronbichler
Journal:  Front Psychiatry       Date:  2020-03-04       Impact factor: 5.435

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.